Literature DB >> 622816

An attempt at passive transfer of immunity to leprosy patients by transfusion of allogeneic lymphocytes, inactivated with mitomycin C.

K Saha, M M Mittal, H B Maheswari.   

Abstract

An attempt was made to repair cell-mediated immunity in 7 patients suffering from lepromatous leprosy and severe erythema nodosum leprosum by intravenous infusion of 400 million allogeneic blood lymphocytes on 3 occasions. The lymphocytes were obtained from lepromin and tuberculin-positive subjects and were inactivated in vitro by treatment with mitomycin C. Immunotherapy with inactivated lymphocytes only modified the severity of erythema nodosum leprosum, without altering other aspects of the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622816     DOI: 10.1111/j.1423-0410.1978.tb03731.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  1 in total

1.  A placebo controlled clinical trial of transfer factor in lepromatous leprosy.

Authors:  W R Faber; D L Leiker; I M Nengerman; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.